Combination therapy with prednisone and isotretinoin in early erythema dyschromicum perstans: A retrospective series
Aisleen Diaz, Ryan Gillihan, Kiran Motaparthi, Adam Rees
Abstract
Erythema dyschromicum perstans (EDP) is an acquired hyperpigmentation disorder characterized by asymptomatic, polycyclic, irregularly shaped light lilac-grey patches surrounded by erythematous borders in the early inflammatory stage and subsequently greyish-blue patches in the later ashy stage. Affected areas include the trunk, neck, face, and upper extremities. Mucous membranes are spared.1 EDP occurs in both children and adults, has a higher frequency noted in women, and is common among Latin American, Asian, and Indian populations.
Topics & Concepts
MedicineDermatologyHyperpigmentationTrunkErythemaAsymptomaticPrednisonePathologySurgeryEcologyBiologyOral Health Pathology and TreatmentAutoimmune and Inflammatory DisordersDermatologic Treatments and Research